PURPOSE: Adverse drug events (ADEs) are harmful and occur with alarming frequency in critically ill patients. Complex pharmacotherapy with multiple medications increases the probability of a drug interaction (DI) and ADEs in patients in intensive care units (ICUs). The objective of the study is to determine the frequency of ADEs among patients in the ICU of a university hospital and the drugs implicated. Also, factors associated with ADEs are investigated. METHODS: This cross-sectional study investigated 299 medical records of patients hospitalized for 5 or more days in an ICU. ADEs were identified through intensive monitoring adopted in hospital pharmacovigilance and also ADE triggers. Adverse drug reactions (ADR) causality was classified using the Naranjo algorithm. Data were analyzed through descriptive analysis, and through univariate and multiple logistic regression. RESULTS: The most frequent ADEs were ADRs type A, of possible causality and moderate severity. The most frequent ADR was drug-induced acute kidney injury. Patients with ADEs related to DIs corresponded to 7% of the sample. The multiple logistic regression showed that length of hospitalization (OR = 1.06) and administration of cardiovascular drugs (OR = 2.2) were associated with the occurrence of ADEs. CONCLUSION: Adverse drug reactions of clinical significance were the most frequent ADEs in the ICU studied, which reduces patient safety. The number of ADEs related to drug interactions was small, suggesting that clinical manifestations of drug interactions that harm patients are not frequent in ICUs.
PURPOSE: Adverse drug events (ADEs) are harmful and occur with alarming frequency in critically illpatients. Complex pharmacotherapy with multiple medications increases the probability of a drug interaction (DI) and ADEs in patients in intensive care units (ICUs). The objective of the study is to determine the frequency of ADEs among patients in the ICU of a university hospital and the drugs implicated. Also, factors associated with ADEs are investigated. METHODS: This cross-sectional study investigated 299 medical records of patients hospitalized for 5 or more days in an ICU. ADEs were identified through intensive monitoring adopted in hospital pharmacovigilance and also ADE triggers. Adverse drug reactions (ADR) causality was classified using the Naranjo algorithm. Data were analyzed through descriptive analysis, and through univariate and multiple logistic regression. RESULTS: The most frequent ADEs were ADRs type A, of possible causality and moderate severity. The most frequent ADR was drug-induced acute kidney injury. Patients with ADEs related to DIs corresponded to 7% of the sample. The multiple logistic regression showed that length of hospitalization (OR = 1.06) and administration of cardiovascular drugs (OR = 2.2) were associated with the occurrence of ADEs. CONCLUSION: Adverse drug reactions of clinical significance were the most frequent ADEs in the ICU studied, which reduces patient safety. The number of ADEs related to drug interactions was small, suggesting that clinical manifestations of drug interactions that harm patients are not frequent in ICUs.
Authors: E Vargas; J Simón; J C Martin; M Puerro; M A Gonzalez-Callejo; M Jaime; B Gomez-Mayoral; F Duque; A Gomez-Delgado; A Moreno Journal: Clin Drug Investig Date: 1998 Impact factor: 2.859
Authors: Emilio Vargas; Ana Terleira; Florentino Hernando; Elia Perez; Carmen Cordón; Alfonso Moreno; Antonio Portolés; Fernando Hernando Journal: Crit Care Med Date: 2003-03 Impact factor: 7.598
Authors: Daniel J Cushing; Michael P Adams; Warren D Cooper; Bing Zhang; Raymond J Lipicky; Peter R Kowey Journal: Am J Cardiol Date: 2009-10-15 Impact factor: 2.778
Authors: William Runciman; Peter Hibbert; Richard Thomson; Tjerk Van Der Schaaf; Heather Sherman; Pierre Lewalle Journal: Int J Qual Health Care Date: 2009-02 Impact factor: 2.038
Authors: Mary Grace Fitzmaurice; Adrian Wong; Hannah Akerberg; Simona Avramovska; Pamela L Smithburger; Mitchell S Buckley; Sandra L Kane-Gill Journal: Drug Saf Date: 2019-09 Impact factor: 5.606
Authors: Zachary L Cox; Allison B McCoy; Michael E Matheny; Gautam Bhave; Neeraja B Peterson; Edward D Siew; Julia Lewis; Ioana Danciu; Aihua Bian; Ayumi Shintani; T Alp Ikizler; Erin B Neal; Josh F Peterson Journal: Clin J Am Soc Nephrol Date: 2013-03-28 Impact factor: 8.237
Authors: M Angeles Fernández de Palencia Espinosa; M Sacramento Díaz Carrasco; José Luis Fuster Soler; Guadalupe Ruíz Merino; M Amelia De la Rubia Nieto; Alberto Espuny Miró Journal: Int J Clin Pharm Date: 2014-09-10